COLUMBIA, S.C., May 20, 2025 /PRNewswire/ -- Ritedose Pharmaceuticals, a division of The Ritedose Corporation (Ritedose), the largest sterile contract development manufacturing organization (CDMO) in ...
COLUMBIA, S.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Ritedose Corporation (Ritedose) announced that the U.S. Food and Drug Administration (FDA) approved its manufacturing and distribution of ...
A Columbia pharmaceutical manufacturer is ramping up production of a critically needed drug in response to a national shortage. Ritedose has launched emergency production of a rare albuterol dosage ...
Ritedose Pharmaceuticals has received the Food and Drug Administration’s approval for manufacturing and distributing generic albuterol sulfate inhalation solution, 0.5% (2.5 mg/0.5 ml). "Driven by the ...
The antibiotic is primarily used for chronic Pseudomonas aeruginosa infections in patients with CF. Tobramycin is an aminoglycoside antibiotic indicated for the treatment of serious bacterial ...
-Ritedose is the development partner and manufacturer of Ohtuvayre (ensifentrine)*, the first inhaled product with a novel mechanism of action in more than 20 years for the maintenance treatment of ...
-Antibiotic is primarily used for chronic Pseudomonas aeruginosa infections in patients with CF COLUMBIA, S.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Ritedose Corporation (Ritedose) announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback